Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs

[1]  J. Peterse,et al.  Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.

[2]  M. Kanda,et al.  Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico‐pathological parameters , 2008, Journal of surgical oncology.

[3]  R. Franco,et al.  Oligomerization of G-protein-coupled receptors: a reality. , 2010, Current opinion in pharmacology.

[4]  W. Ding,et al.  Zinc-binding compounds induce cancer cell death via distinct modes of action. , 2007, Cancer letters.

[5]  Eugene Berezikov,et al.  Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis. , 2006, Genome research.

[6]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[7]  M. West,et al.  Gene expression predictors of breast cancer outcomes , 2003, The Lancet.

[8]  Jong-Hyeon Jeong,et al.  Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. , 2002, The New England journal of medicine.

[9]  C Hill,et al.  Interpretation of microarray data in cancer , 2007, British Journal of Cancer.

[10]  Chunlei Wu,et al.  Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis , 2004, Cancer.

[11]  Lee M Ellis,et al.  Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells , 2005, Oncogene.

[12]  D. Martinez-Ramos,et al.  Disease-Free Survival and Prognostic Significance of Metastatic Lymph Node Ratio in T1-T2 N Positive Breast Cancer Patients. A Population Registry-Based Study in a European Country , 2009, World Journal of Surgery.

[13]  Kornelia Polyak,et al.  Microenvironmental regulation of cancer development. , 2008, Current opinion in genetics & development.

[14]  C. Yip,et al.  Predictors of Axillary Lymph Node Metastases in Breast Cancer: Is There a Role for Minimal Axillary Surgery? , 2008, World Journal of Surgery.

[15]  Richard Simon,et al.  Roadmap for developing and validating therapeutically relevant genomic classifiers. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  L. Ellis,et al.  Vascular endothelial growth factor receptor‐1 promotes migration and invasion in pancreatic carcinoma cell lines , 2005, Cancer.

[17]  King-Jen Chang,et al.  Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer. , 2008, Breast.

[18]  Doron Betel,et al.  The microRNA.org resource: targets and expression , 2007, Nucleic Acids Res..

[19]  Gavin C. Cawley,et al.  Leave-One-Out Cross-Validation Based Model Selection Criteria for Weighted LS-SVMs , 2006, The 2006 IEEE International Joint Conference on Neural Network Proceedings.

[20]  Y. Carmi,et al.  The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions , 2006, Cancer and Metastasis Reviews.

[21]  Meenhard Herlyn,et al.  Axis of evil: molecular mechanisms of cancer metastasis , 2003, Oncogene.

[22]  D. Chakravarty,et al.  Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[23]  W. Godolphin,et al.  Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis. , 1988, Cancer research.

[24]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.

[25]  Hiroyuki Aburatani,et al.  Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis , 2006, Nature Cell Biology.

[26]  Xuchen Cao,et al.  Expression level of insulin‐like growth factor binding protein 5 mRNA is a prognostic factor for breast cancer , 2007, Cancer science.

[27]  George A Calin,et al.  MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. , 2009, Cancer research.

[28]  J. Haerting,et al.  Gene-expression signatures in breast cancer. , 2003, The New England journal of medicine.

[29]  R. Simmons,et al.  Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients. , 2000, Journal of the American College of Surgeons.

[30]  Clara Alsinet,et al.  [Genomic prognostic markers in hepatocellular carcinoma]. , 2012, Gastroenterologia y hepatologia.

[31]  H. Dai,et al.  No common denominator for breast cancer lymph node metastasis , 2005, British Journal of Cancer.

[32]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Caligiuri,et al.  The BRG1- and hBRM-Associated Factor BAF57 Induces Apoptosis by Stimulating Expression of the Cylindromatosis Tumor Suppressor Gene , 2005, Molecular and Cellular Biology.

[34]  I. Mittra,et al.  A meta-analysis of reported correlations between prognostic factors in breast cancer: does axillary lymph node metastasis represent biology or chronology? , 1991, European journal of cancer.

[35]  Yusuke Nakamura,et al.  Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis. , 2004, International journal of oncology.

[36]  Bing Zhang,et al.  GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies , 2004, BMC Bioinformatics.

[37]  A. Bittner,et al.  Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer , 2009, BMC Cancer.

[38]  M. Seto,et al.  MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. , 2010, Cancer research.

[39]  Johan A. K. Suykens,et al.  Least Squares Support Vector Machine Classifiers , 1999, Neural Processing Letters.

[40]  S. Fox,et al.  VEGF‐B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis , 2001, The Journal of pathology.

[41]  M Tubiana,et al.  The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and the initiation of distant metastases. , 1989, British Journal of Cancer.

[42]  P. Schirmacher,et al.  S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis , 2009, Hepatology.

[43]  J. Llovet,et al.  New Strategies in Hepatocellular Carcinoma: Genomic Prognostic Markers , 2010, Clinical Cancer Research.

[44]  T. Eberlein.  Relationship Between Age and Axillary Lymph Node Involvement in Women With Breast Cancer , 2010 .

[45]  H. Heneghan,et al.  MiRNAs as biomarkers and therapeutic targets in cancer. , 2010, Current opinion in pharmacology.

[46]  Joel Greshock,et al.  MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. , 2008, Cancer research.

[47]  Ava Kwong,et al.  MicroRNAs as New Players for Diagnosis, Prognosis, and Therapeutic Targets in Breast Cancer , 2009, Journal of oncology.

[48]  L. Coussens,et al.  The tumor microenvironment: a critical determinant of neoplastic evolution. , 2003, European journal of cell biology.

[49]  A. Valleron,et al.  The Natural History of Human Breast Cancer , 1981 .

[50]  S G Hilsenbeck,et al.  Significance of axillary lymph node metastasis in primary breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  A. Ribeiro-Silva,et al.  Tumor-infiltrating CD4+ T lymphocytes in early breast cancer reflect lymph node involvement. , 2006, Clinics.

[52]  Kotb Abdelmohsen,et al.  miR-519 suppresses tumor growth by reducing HuR levels , 2010, Cell cycle.